MARKET

LGND

LGND

Ligand Pharma
NASDAQ
218.31
+10.53
+5.07%
Opening 12:09 05/20 EDT
OPEN
211.52
PREV CLOSE
207.78
HIGH
218.70
LOW
210.41
VOLUME
69.29K
TURNOVER
--
52 WEEK HIGH
247.38
52 WEEK LOW
98.89
MARKET CAP
4.38B
P/E (TTM)
29.41
1D
5D
1M
3M
1Y
5Y
1D
Ligand Pharmaceuticals Bets Big on Royalty Growth
TipRanks · 18h ago
Ligand Pharma Advances XOMA Royalty Acquisition with Amendment
TipRanks · 2d ago
XOMA Royalty amends Ligand merger deal to add HoldCo as party
PUBT · 2d ago
Ligand amends XOMA Royalty merger agreement to add new holding company entity
PUBT · 2d ago
Weekly Report: what happened at LGND last week (0511-0515)?
Weekly Report · 2d ago
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), NeuroPace (NPCE) and Avalo Therapeutics (AVTX)
TipRanks · 6d ago
RBC Capital Keeps Their Buy Rating on Ligand Pharma (LGND)
TipRanks · 05/12 11:21
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ligand Pharma (LGND), Pliant Therapeutics (PLRX) and Oculis Holding (OCS)
TipRanks · 05/12 11:21
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. It does this by financing, licensing its technologies or both. It operates two infrastructure-light royalty-generating IP platform technologies. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled FDA-approved products, including Gilead’s Veklury, Amgen’s Kyprolis, Baxter’s Nexterone, and Acrotech Biopharma’s Evomela. Its NITRICIL platform technology facilitates tunable dosing, permitting an adjustable drug release profile to allow proprietary formulations that target a range of indications. Its technologies also include HepDirect, LTP and BEPro Technology Platform, and Pelican Expression Technology. It has multiple alliances, licenses and other business relationships with various pharmaceutical companies.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.